Suunto has introduced the Vertical 2, the latest model in its adventure watch lineup. It is built for extreme expeditions and daily outdoor use. The new watch features a redesigned optical heart rate ...
Oct 15 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab and Omeros (OMER.O), opens new tab have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's ...
Novo Nordisk is drawing divided views from Wall Street analysts. Some may be disappointed by the loss of market share to Eli Lilly. Three events could turn sentiment positive in the coming months. The ...
Novo Nordisk is drawing divided views from Wall Street analysts. The HSBC approach, in this case, may be sensible, at least on a risk-reward basis. The nearly 50% drop in Novo Nordisk shares is likely ...
LONDON/SAN FRANCISCO, Oct 15 (Reuters) - Drugmaker Novo Nordisk (NOVOb.CO), opens new tab has begun a round of layoffs in its most important market, the United States, with affected staff set to be ...
FILE - This photo shows Novo Nordisk headquarters in Bagsvaerd, Denmark, on Feb. 5, 2025. (Mads Claus Rasmussen/Ritzau Scanpix via AP, File) NEW YORK (AP) — Armed with hundreds of thousands of dollars ...
Novo Nordisk has reduced the price of its two semaglutide-based therapies – Ozempic for diabetes and Wegovy for obesity – to a price of $499 for those paying for the drugs out of pocket. The price cut ...
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback